BioSpace News Archive

Genetown

Oxford Biomedica Solutions Publishes Peer-Reviewed Journal Article On Novel Dual-Plasmid System, Resulting In Significantly Increased AAV Vector Productivity And Percentage Of Full Capsids Packaged

Oxford Biomedica Solutions LLC, offers The Full Solution™ suite of services, which includes end-to-end development and manufacturing capabilities for cell and gene therapy.

June 8, 2023
·
1 min read
Pharm Country

Qosina Partners with Carolina Components to Market their FlowLinX™ Line of Bioprocess Components

Qosina is happy to announce its partnership with Carolina Components Group, a leading supplier of primary and support production materials for the pharmaceutical and biotech manufacturing industries.

June 8, 2023
·
3 min read
GenScript ProBio and Comprehensive Cell Solutions Form a Pioneering Partnership to Expedite Cell and Gene Therapy Development and Manufacturing

GenScript ProBio, a global contract development and manufacturing organization, and Comprehensive Cell Solutions (CCS), a leader in cell therapy development and manufacturing, have partnered to spearhead

June 8, 2023
·
4 min read
Drug Development

Large Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s house dust mite tablet in young children

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced top-line results from a Phase 3 pediatric clinical trial of its sublingual allergy immunotherapy tablet for the treatment of house dust mite (HDM)-induced allergic rhinitis.

June 8, 2023
·
4 min read
Corning and SGD Pharma announce joint venture to open new glass tubing facility and expand access to Corning® Velocity® Vial technology in India

Corning Incorporated (NYSE:GLW) and SGD Pharma today announced a joint venture that includes the opening of a new glass tubing facility to expand pharmaceutical manufacturing

June 8, 2023
·
8 min read
Business

Abivax Appoints Ida Hatoum as Chief People Officer

Abivax SA (Euronext Paris: FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune system to treat patients with chronic inflammatory diseases, today announces the appointment of Ida Hatoum as Chief People Officer.

June 8, 2023
·
5 min read
Abivax Releases the Results of its June 5, 2023 Ordinary and Extraordinary General Meeting

Abivax SA (Euronext Paris: FR0012333284 - ABVX) held its ordinary and extraordinary general meeting of shareholders on June 5, 2023, which was chaired by Marc de Garidel, CEO of Abivax and interim Chairman of the Board of Directors.

June 8, 2023
·
2 min read
LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business

LTS LOHMANN Therapie-Systeme AG (“LTS”) has completed its acquisition of the Sorrel wearable injection device business (“Sorrel”) with headquarters in Netanya, Israel, from Eitan Medical Ltd (“Eitan Medical”).

June 8, 2023
·
2 min read
Pharm Country

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

June 8, 2023
·
5 min read
Business

SOTERIA Precision Medicine Foundation Opens Cancer Research Study Leveraging Certis Oncology Solutions’ Predictive Artificial Intelligence Platform and Functional Assays

SOTERIA Precision Medicine Foundation, an organization dedicated to empowering patients, caregivers, and clinicians with the power of precision medicine, today announced a fiscal sponsorship agreement with Certis Oncology Solutions, a San Diego-based precision oncology and translational science company.

June 8, 2023
·
5 min read